OVARIAN AGING VALUE

Build an AI-powered health-economic model to quantify the societal value of delaying menopause and improving ovarian healthspan for women's longevity.

> WHY_IT_MATTERS

The aging of the ovaries is a fundamental biological process that drives menopause, a tipping point in a woman's health that accelerates the risk for major diseases like heart disease, osteoporosis, and dementia.

A woman's age at natural menopause is strongly correlated with her overall longevity and healthspan. Ovaries age faster than nearly every other organ and serve as a 'canary in the coalmine' for overall aging.

Despite this profound impact, research into extending ovarian healthspan is critically underfunded, partly because its full economic and health consequences remain unquantified.

> THE_MISSION

Your mission is to build a tool that synthesizes research findings and calculates the net benefit of delaying menopause, with a focus on those women who experience an earlier-than-average transition.

Using AI to synthesize published literature and public datasets, you will produce a balanced, evidence-based model that quantifies the societal value unlocked by improving ovarian healthspan.

> APPROACH

AI-POWERED HEALTH-ECONOMIC MODELING

This project sits at the intersection of AI, health economics, and longevity science. Using modern AI tools, your team will systematically review published literature and datasets to build a comprehensive model.

1.
Synthesis: Identify and extract risk data (Odds Ratios, Hazard Ratios) from broad sources linking age at menopause to specific diseases.
2.
Impact Modeling: Develop a model that calculates the net change in disease cases (both positive and negative) resulting from a 2/5/10 year therapeutic delay in menopause.
3.
Economic Analysis: Translate the health outcomes into a clear economic case by integrating per-patient healthcare costs and productivity data.

> BLUEPRINT

COMPONENT 1: AI-POWERED EVIDENCE SYNTHESIS

Build a robust pipeline to systematically review scientific literature and build a structured dataset of risks associated with earlier menopause. Your goal is to find studies that link the timing of menopause to specific health outcomes.

HEALTH CONDITIONS TO MODEL:

  • Cardiovascular Disease (CVD): Distinguish between general CVD, stroke, myocardial infarction, etc.
  • Osteoporosis & Fracture Risks
  • Dementia
  • Breast Cancer
  • Immediate Menopause Symptoms: Vasomotor symptoms, cognitive changes, quality of life

KEY RISK METRICS TO EXTRACT:

  • Odds Ratios (OR): Compares the odds of a disease in "early menopause" vs. "normal menopause" groups
  • Hazard Ratios (HR): Measures how the rate of disease onset changes based on menopause timing
  • Relative Risks (RR): Compares the probability of a disease between two groups

DATA VALIDITY SCORING:

Implement a validity scoring system to extract only high-quality data:

  • Simple: Hierarchy of Evidence Model - scores studies based on design type (cohort study vs. case-control)
  • Robust: Risk of Bias Checklist - scores studies on internal quality (controlling for confounders, race, socioeconomic status, study size)

PHASE 2: BALANCED HEALTH IMPACT MODELING

CORE TASK:

Develop a model that calculates the annual change in disease cases per 100,000 women (in the U.S. and/or U.K.) resulting from a therapeutic 5-year delay in menopause. Focus on women undergoing menopause earlier than average (~50-51 years).

STRETCH GOAL:

Create a version with a variable time scale, allowing for analysis of 2-year, 10-year delays, or other timings.

⚠️ CRITICAL REQUIREMENT: SCIENTIFIC CREDIBILITY

Your analysis must model both benefits and risks of prolonged estrogen exposure:

  • Benefits: Reduced risk of CVD, osteoporosis, dementia
  • Increased Risks: Breast Cancer, Endometrial Cancer, Ovarian Cancer (due to larger lifetime dose of estrogens)

PHASE 3: THE ECONOMIC ANALYSIS

Translate your health impact findings into a clear economic case.

CORE TASK:

Convert the "net cases averted/added" from your model into a dollar value:

  • Direct Healthcare Costs: Average annual per-patient cost of care for each disease (use HCUP, academic papers, government health reports)

STRETCH GOAL:

  • Indirect Productivity Costs: Estimate economic value of increased workforce participation and reduced absenteeism

> DELIVERABLE

THE GOAL

A robust, data-driven visualization that demonstrates the net benefits of delaying ovarian aging, including appropriate sourcing and rationalization.

This can take the form of a report, a tool, or an interactive dashboard for educational purposes. This analysis will serve as a compelling justification for investors, policymakers, and researchers to increase focus and funding in women's health.

REQUIRED SUBMISSIONS:

1.Methodology Documentation: Clearly outlined methodology for the entire report and all quantified conclusions
2.Codebase & Datasets: Full synthesized datasets used and all code
3.
Visualization: Presentation of the data is up to you. The goal is clarity and impact.

Example Ideas:

  • • Interactive dashboard showing the "Ripple Effect" of preventing early menopause on healthcare budgets over 10 years
  • • Comparative "Life Path" infographic showing health and financial journey of a woman with early vs. average menopause
  • • Dynamic chart quantifying trade-offs between different interventions

> RESOURCES

McKinsey Report on Women's Health Gap

Excellent estimate of the economic costs of women's healthcare gaps, including during menopause. Provides robust framework for calculating economic and productivity losses.

AHA Study on CVD in Menopause

Landmark study on relationship between CVD risk and the menopausal transition, with ample sourcing.

Age at Menopause & Bone Density/Fracture Risk

Study on association between age at menopause, bone matter density, and risk of fractures.